Evidence map›Paper›PMID 21844206›Full record

ArticleThe Journal of experimental medicine2011

The Paf oncogene is essential for hematopoietic stem cell function and development.

Yacine M Amrani, Jonathan Gill, Armine Matevossian, Eric S Alonzo, Chingwen Yang, Jae-Hung Shieh, Malcolm A Moore, Christopher Y Park, Derek B Sant'Angelo, Lisa K Denzin

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Deletion of Mouse Setd4 Promotes the Recovery of Hematopoietic Failure.International journal of radiation oncology, biology, physics · 2020
    Article
  5. Article
  6. Review
  7. Animal models and experimental medicine · 2018
    Article
  8. PAF promotes stemness and radioresistance of glioma stem cells.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Yacine M AmraniImmunology Program, Sloan-Kettering Institute, 3 Department of Pediatrics, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Jonathan Gill
Armine Matevossian
Eric S Alonzo
Chingwen Yang
Jae-Hung Shieh
Malcolm A Moore
Christopher Y Park
Derek B Sant'Angelo
Lisa K Denzin
Memorial Sloan Kettering Cancer Center · USKettering University · USPediatrics and Genetics · USRockefeller University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Translational linkage strategies for DNA vaccines against cancerF31CA130744 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI ALONZO, ERIC SCOTT · 2007 to 2010
$165k
NCI NIH HHS F31 CA130744NCI NIH HHS F31CA130744NCI NIH HHS P30 CA008748NCI NIH HHS P30-CA 08748
6 · The paper itself

Abstract

Hematopoietic stem cells (HSCs) self-renew to maintain the lifelong production of all blood populations. Here, we show that the proliferating cell nuclear antigen-associated factor (Paf) is highly expressed in cycling bone marrow HSCs and plays a critical role in hematopoiesis. Mice lacking Paf exhibited reduced bone marrow cellularity; reduced numbers of HSCs and committed progenitors; and leukopenia. These phenotypes are caused by a cell-intrinsic blockage in the development of long-term (LT)-HSCs into multipotent progenitors and preferential loss of lymphoid progenitors caused by markedly increased p53-mediated apoptosis. In addition, LT-HSCs from Paf(-/-) mice had increased levels of reactive oxygen species (ROS), failed to maintain quiescence, and were unable to support LT hematopoiesis. The loss of lymphoid progenitors was likely due the increased levels of ROS in LT-HSCs caused by treatment of Paf(-/-) mice with the anti-oxidant N-acetylcysteine restored lymphoid progenitor numbers to that of Paf(+/+) mice. Collectively, our studies identify Paf as a novel and essential regulator of early hematopoiesis.

Indexed as

AcetylcysteineAnimalsApoptosisCarrier ProteinsFree Radical ScavengersHematopoiesisLeukopeniaLymphoid Progenitor CellsMiceMice, KnockoutOncogene ProteinsReactive Oxygen SpeciesTime FactorsTumor Suppressor Protein p53AcetylcysteineCarrier ProteinsFree Radical ScavengersOncogene ProteinsPAF protein, mouseReactive Oxygen SpeciesTumor Suppressor Protein p53

Identifiers

PMID21844206
PMCPMC3171089
OpenAlexW2087430697

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.